Trial Information

Summary: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Female Patients With Stable Angina Pectoris Who are Not Candidates for Revascularization.

Researchers at Massachusetts General Hospital in Boston, MA are currently enrolling women who suffer from chest pain due to heart disease. If you have had a prior bypass graft or stent procedure but still have chest pain, and can take an exercise treadmill test, you may be eligible to enroll in this research study. The study includes 2-3 screening visits, 6 study visits, and yearly phone follow-up for four years. The study will reimburse out-of-pocket expenses. If you are interested in participating or would like more information please contact Voula Christopoulos, the research coordinator, at 617-643-2890 or by e-mail at vchristopoulos1@partners.org

Contact:

Voula E Christopoulos, CRC
MGH - Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Telephone: 617-643-2890
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 17, 2008 at 2:55:48 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA